Yutaka Yamamoto

12PUBLICATIONS
30CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical biochemistry - proteins and peptides (incl. medical proteomics)Radiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 02, 2026
Clinical Impact of Gleason Pattern 5 on Doublet Versus Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer.

|Aug 14, 2025
Comparison of Oncological Outcomes of Conventional Androgen Deprivation Therapy (ADT) and ADT Plus Androgen Receptor Signaling Inhibitor in Older Patients With Metastatic Castration-Sensitive Prostate Cancer.

Yutaka Yamamoto, Saizo Fujimoto, Mamoru Hashimoto

|Jul 27, 2025
Prognostic Impact of Initial Prostate-Specific Antigen in Metastatic Hormone-Sensitive Prostate Cancer Patients With Extensive Bone Metastases Under Androgen Receptor Signaling Inhibitor.

Saizo Fujimoto, Tsuyoshi Morita, Yutaka Yamamoto

|Apr 24, 2025
Comorbid Diabetes Mellitus Contributes to Residual Overactive Bladder After Transurethral Surgery for Benign Prostatic Hyperplasia.

Koji Miki, Keisuke Kiba, Daisuke Maenosono

|Mar 24, 2025
Editorial Comments to "Overuse of Imaging in Prostate Cancer Staging".

Yutaka Yamamoto

|Feb 12, 2025
Relationship Between the First Undisturbed Sleep Period and Diuretic and Urine Storage States of the First Void After Sleep.

Yasunori Akashi, Koji Miki, Keisuke Kiba

Pageof 2

Frequent Collaborators

4 joint publications

Kazutoshi Fujita

3 joint publications

Akihide Hirayama

3 joint publications

Ryoichi Maenosono

3 joint publications

Takafumi Minami